{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:56:23Z","timestamp":1789656983073,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01409-x","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:11:25Z","timestamp":1770034285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic Dysfunction\u2013Associated Steatotic Liver Disease after Pancreatoduodenectomy: an Underestimated Metabolic Complication Driven by Unique Pathophysiological Mechanisms"],"prefix":"10.1007","volume":"57","author":[{"given":"Andrea","family":"Tehuitzil-Cordero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Montalvo-Jav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misael","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-2661","authenticated-orcid":false,"given":"Natalia","family":"Nu\u00f1o-L\u00e1mbarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"1409_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke F, Horn P, Wai-Sun Wong V, Ratziu V, Bugianesi E, Francque S, et al. EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","journal-title":"J Hepatol"},{"key":"1409_CR2","doi-asserted-by":"publisher","unstructured":"Pustjens J, van Kleef LA, Janssen HLA, de Knegt RJ, Brouwer WP. Differential prevalence and prognostic value of metabolic syndrome components among MASLD patients. JHEP Rep Elsevier BV. 2024;101193. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101193.","DOI":"10.1016\/j.jhepr.2024.101193"},{"key":"1409_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/JSO.23693","volume":"110","author":"N Nakagawa","year":"2014","unstructured":"Nakagawa N, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, et al. Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency. J Surg Oncol. 2014;110:720\u20136. https:\/\/doi.org\/10.1002\/JSO.23693.","journal-title":"J Surg Oncol"},{"key":"1409_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/00000658-200006000-00014","volume":"231","author":"JJ Huang","year":"2000","unstructured":"Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman JA, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg. 2000;231:890\u20138. https:\/\/doi.org\/10.1097\/00000658-200006000-00014.","journal-title":"Ann Surg"},{"key":"1409_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4254\/wjh.v5.i4.189","volume":"5","author":"D Satoh","year":"2013","unstructured":"Satoh D, Yagi T, Nagasaka T, Shinoura S, Umeda Y, Yoshida R, et al. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. World J Hepatol. 2013;5:189\u201395. https:\/\/doi.org\/10.4254\/wjh.v5.i4.189.","journal-title":"World J Hepatol"},{"key":"1409_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/J.JAMCOLLSURG.2020.08.761","volume":"231","author":"K Yasukawa","year":"2020","unstructured":"Yasukawa K, Shimizu A, Yokoyama T, Kubota K, Notake T, Seki H, et al. Preventive effect of high-dose digestive enzyme management on development of nonalcoholic fatty liver disease after pancreaticoduodenectomy: a randomized controlled clinical trial. J Am Coll Surg. 2020;231:658\u201369. https:\/\/doi.org\/10.1016\/J.JAMCOLLSURG.2020.08.761.","journal-title":"J Am Coll Surg"},{"key":"1409_CR7","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797\u2013835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323.","journal-title":"Hepatology"},{"key":"1409_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34:969-977.e2. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.003.","journal-title":"Cell Metab"},{"key":"1409_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cld.2015.10.002","volume-title":"Clin Liver Dis","author":"P Kanwar","year":"2016","unstructured":"Kanwar P, Kowdley KV. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. In: Clin Liver Dis. W.B. Saunders; 2016. p. 225\u201343. https:\/\/doi.org\/10.1016\/j.cld.2015.10.002."},{"key":"1409_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijsu.2018.09.002","volume":"58","author":"C Luu","year":"2018","unstructured":"Luu C, Thapa R, Rose T, Woo K, Jeong D, Thomas K, et al. Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm. Int J Surg. 2018;58:46\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2018.09.002.","journal-title":"Int J Surg"},{"key":"1409_CR11","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.3390\/NU7115475","volume":"7","author":"C Saponaro","year":"2015","unstructured":"Saponaro C, Gaggini M, Carli F, Gastaldelli A. The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients Nutrients. 2015;7:9453\u201374. https:\/\/doi.org\/10.3390\/NU7115475.","journal-title":"Nutrients Nutrients"},{"key":"1409_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/JHBP.115","volume":"21","author":"R Sato","year":"2014","unstructured":"Sato R, Kishiwada M, Kuriyama N, Azumi Y, Mizuno S, Usui M, et al. Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2014;21:562\u201372. https:\/\/doi.org\/10.1002\/JHBP.115.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1409_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/S00534-009-0187-2","volume":"17","author":"H Kato","year":"2010","unstructured":"Kato H, Isaji S, Azumi Y, Kishiwada M, Hamada T, Mizuno S, et al. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci. 2010;17:296\u2013304. https:\/\/doi.org\/10.1007\/S00534-009-0187-2.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1409_CR14","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1007\/S00268-010-0636-8","volume":"34","author":"HH Yu","year":"2010","unstructured":"Yu HH, Shan YS, Lin PW. Effect of pancreaticoduodenectomy on the course of hepatic steatosis. World J Surg World J Surg. 2010;34:2122\u20137. https:\/\/doi.org\/10.1007\/S00268-010-0636-8.","journal-title":"World J Surg World J Surg"},{"key":"1409_CR15","doi-asserted-by":"publisher","unstructured":"Miura H, Ijichi M, Ando Y, Hayama K, IIhara K, Yamada H, et al. A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy. Clin J Gastroenterol. 2013(6). https:\/\/doi.org\/10.1007\/S12328-013-0421-Y.","DOI":"10.1007\/S12328-013-0421-Y"},{"key":"1409_CR16","doi-asserted-by":"publisher","unstructured":"Nomura R, Ishizaki Y, Suzuki K, Kawasaki S, Nomura R, Ishizaki Y,et al. Development of hepatic steatosis after pancreatoduodenectomy. Am Roentgen Ray Soc. 2012;189:1484\u20138. https:\/\/doi.org\/10.2214\/AJR.07.2809","DOI":"10.2214\/AJR.07.2809"},{"key":"1409_CR17","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/00365521.2023.2200452","volume":"58","author":"H Maetzel","year":"2023","unstructured":"Maetzel H, Rutkowski W, Panic N, Mari A, Hedstr\u00f6m A, Kulinski P, et al. Non-alcoholic fatty pancreas disease and pancreatic exocrine insufficiency: pilot study and systematic review. Scand J Gastroenterol. 2023;58:1030\u20137. https:\/\/doi.org\/10.1080\/00365521.2023.2200452.","journal-title":"Scand J Gastroenterol"},{"key":"1409_CR18","doi-asserted-by":"publisher","first-page":"12946","DOI":"10.12998\/WJCC.V10.I35.12946","volume":"10","author":"P Shah","year":"2022","unstructured":"Shah P, Patel V, Ashkar M. De novo non-alcoholic fatty liver disease after pancreatectomy: a systematic review. World J Clin Cases World J Clin Cases. 2022;10:12946\u201358. https:\/\/doi.org\/10.12998\/WJCC.V10.I35.12946.","journal-title":"World J Clin Cases World J Clin Cases"},{"key":"1409_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/AGS3.12024","volume":"1","author":"Y Fujii","year":"2017","unstructured":"Fujii Y, Nanashima A, Hiyoshi M, Imamura N, Yano K, Hamada T, et al. Risk factors for development of nonalcoholic fatty liver disease after pancreatoduodenectomy. Ann Gastroenterol Surg. 2017;1:226\u201331. https:\/\/doi.org\/10.1002\/AGS3.12024.","journal-title":"Ann Gastroenterol Surg"},{"key":"1409_CR20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/S00535-011-0370-5","volume":"46","author":"N Tanaka","year":"2011","unstructured":"Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol. 2011;46:758\u201368. https:\/\/doi.org\/10.1007\/S00535-011-0370-5.","journal-title":"J Gastroenterol"},{"key":"1409_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jss.2024.07.013","volume":"302","author":"K Huang","year":"2024","unstructured":"Huang K, Qian T, Chen W, Bai X, Gao S, Shen Y, et al. Clinical significance and risk factors of nonalcoholic fatty liver diseases after Whipple procedure. J Surg Res. 2024;302:706\u201314. https:\/\/doi.org\/10.1016\/j.jss.2024.07.013.","journal-title":"J Surg Res"},{"key":"1409_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/J.GASSUR.2024.03.025","volume":"28","author":"K Sugumar","year":"2024","unstructured":"Sugumar K, Naik L, Hue JJ, Ammori JB, Hardacre JM, Ocuin LM, et al. Risk factors of developing nonalcoholic fatty liver disease after pancreatic resection: a systematic review and meta-analysis. J Gastrointest Surg. 2024;28:983\u201392. https:\/\/doi.org\/10.1016\/J.GASSUR.2024.03.025.","journal-title":"J Gastrointest Surg"},{"key":"1409_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbacli.2015.02.001","volume":"3","author":"T Nagaya","year":"2015","unstructured":"Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, et al. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. BBA Clin. 2015;3:168\u201374. https:\/\/doi.org\/10.1016\/j.bbacli.2015.02.001.","journal-title":"BBA Clin"},{"key":"1409_CR24","doi-asserted-by":"publisher","unstructured":"Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, et al. Early detection of pancreatic cancer. The Lancet Gastroenterology & Hepatology. 2020. https:\/\/doi.org\/10.1016\/S2468-1253(19)30416-9.","DOI":"10.1016\/S2468-1253(19)30416-9"},{"key":"1409_CR25","doi-asserted-by":"publisher","unstructured":"Klein AP, Nature Publishing Group. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nature Reviews Gastroenterology & Hepatology. 2021(7). https:\/\/doi.org\/10.1038\/s41575-021-00457-x.","DOI":"10.1038\/s41575-021-00457-x"},{"key":"1409_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/J.PAN.2022.08.002","volume":"22","author":"VJ Kroon","year":"2022","unstructured":"Kroon VJ, Daamen LA, Tseng DSJ, de Vreugd AR, Brada LJH, Busch OR, et al. Pancreatic exocrine insufficiency following pancreatoduodenectomy: a prospective bi-center study. Pancreatology. 2022;22:1020\u20137. https:\/\/doi.org\/10.1016\/J.PAN.2022.08.002.","journal-title":"Pancreatology"},{"key":"1409_CR27","doi-asserted-by":"publisher","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2023;34. https:\/\/doi.org\/10.1016\/j.annonc.2023.08.009.","DOI":"10.1016\/j.annonc.2023.08.009"},{"key":"1409_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032782","volume":"102","author":"V Patel","year":"2023","unstructured":"Patel V, Shah P, Ludwig DR, Hammill CW, Ashkar M. Development of de novo nonalcoholic fatty liver disease following pancreatectomy. Medicine (Baltimore). 2023;102:E32782. https:\/\/doi.org\/10.1097\/MD.0000000000032782.","journal-title":"Medicine (Baltimore)"},{"key":"1409_CR29","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1264-1281.e4. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036.","journal-title":"Gastroenterology"},{"key":"1409_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-012-9912-4","author":"P Bhosale","year":"2013","unstructured":"Bhosale P, Fleming J, Balachandran A, Charnsangavej C, Tamm EP. Complications of Whipple surgery: imaging analysis. Abdom Imaging. 2013. https:\/\/doi.org\/10.1007\/s00261-012-9912-4.","journal-title":"Abdom Imaging"},{"key":"1409_CR31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/S11605-020-04641-3","volume":"24","author":"JA Brown","year":"2020","unstructured":"Brown JA, Zenati MS, Simmons RL, Al Abbas AI, Chopra A, Smith K, et al. Long-term surgical complications after pancreatoduodenectomy: incidence, outcomes, and risk factors. J Gastrointest Surg. 2020;24:1581\u20139. https:\/\/doi.org\/10.1007\/S11605-020-04641-3.","journal-title":"J Gastrointest Surg"},{"key":"1409_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/JHBP.1093","volume":"29","author":"H Kato","year":"2022","unstructured":"Kato H, Kamei K, Suto H, Misawa T, Unno M, Nitta H, et al. Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: a first multicenter prospective study in Japan. J Hepatobiliary Pancreat Sci. 2022;29:428\u201338. https:\/\/doi.org\/10.1002\/JHBP.1093.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1409_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/JHBP.318","volume":"23","author":"S Satoi","year":"2016","unstructured":"Satoi S, Sho M, Yanagimoto H, Yamamoto T, Akahori T, Kinoshita S, et al. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial. J Hepatobiliary Pancreat Sci. 2016;23:167\u201373. https:\/\/doi.org\/10.1002\/JHBP.318.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1409_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.hpb.2023.10.002","volume":"26","author":"CS Leonhardt","year":"2024","unstructured":"Leonhardt CS, Niesen W, Pils D, Angelova Y, Hank T, Kaiser J, et al. Patient reported outcomes of duodenum-preserving pancreatic head resection in chronic pancreatitis: high effectivity is impaired by prolonged non-surgical management. HPB. 2024;26:73\u201382. https:\/\/doi.org\/10.1016\/j.hpb.2023.10.002.","journal-title":"HPB"},{"key":"1409_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1177\/000313481408000523","volume":"80","author":"Y Ito","year":"2014","unstructured":"Ito Y, Kenmochi T, Shibutani S, Egawa T, Hayashi S, Nagashima A, et al. Evaluation of predictive factors in patients with nonalcoholic fatty liver disease after pancreaticoduodenectomy. Am Surg. 2014;80:500\u20134. https:\/\/doi.org\/10.1177\/000313481408000523.","journal-title":"Am Surg"},{"key":"1409_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/JHBP.14","volume":"21","author":"M Nagai","year":"2014","unstructured":"Nagai M, Sho M, Satoi S, Toyokawa H, Akahori T, Yanagimoto H, et al. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2014;21:186\u201392. https:\/\/doi.org\/10.1002\/JHBP.14.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1409_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.14218\/JCTH.2015.00029","volume":"3","author":"S Olefson","year":"2015","unstructured":"Olefson S, Jackson M, Grand DJ, Charpentier KP, Makwana N, Promrat K. Identification of nonalcoholic fatty liver disease following pancreatic surgery in a Western cohort using a novel radiographic technique. J Clin Transl Hepatol. 2015;3:246\u201353. https:\/\/doi.org\/10.14218\/JCTH.2015.00029.","journal-title":"J Clin Transl Hepatol"},{"key":"1409_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002535","author":"K Ohgi","year":"2016","unstructured":"Ohgi K, Okamura Y, Yamamoto Y, Ashida R, Ito T, Sugiura T, et al. Perioperative computed tomography assessments of the pancreas predict nonalcoholic fatty liver disease after pancreaticoduodenectomy. Med. 2016. https:\/\/doi.org\/10.1097\/MD.0000000000002535.","journal-title":"Med"},{"key":"1409_CR39","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/JSO.25051","volume":"117","author":"TM Mackay","year":"2018","unstructured":"Mackay TM, Gen\u00e7 CG, Takkenberg RB, Besselink MG, Somers I, van Nieveen Dijkum EJM. New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors. J Surg Oncol. 2018;117:1548\u201355. https:\/\/doi.org\/10.1002\/JSO.25051.","journal-title":"J Surg Oncol"},{"key":"1409_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/S00595-019-01866-X","volume":"50","author":"H Okabe","year":"2020","unstructured":"Okabe H, Yamashita Y, ichi, Inoue R, Kinoshita S, Itoyama R, Yusa T, et al. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy. Surg Today Surg Today. 2020;50:193\u20139. https:\/\/doi.org\/10.1007\/S00595-019-01866-X.","journal-title":"Surg Today Surg Today"},{"key":"1409_CR41","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1245\/S10434-022-11946-X","volume":"29","author":"G Guarneri","year":"2022","unstructured":"Guarneri G, Palumbo D, Pecorelli N, Prato F, Gritti C, Cerchione R, et al. The impact of CT-assessed liver steatosis on postoperative complications after pancreaticoduodenectomy for cancer. Ann Surg Oncol. 2022;29:7063\u201373. https:\/\/doi.org\/10.1245\/S10434-022-11946-X.","journal-title":"Ann Surg Oncol"},{"key":"1409_CR42","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/JHBP.1150","volume":"29","author":"D Jeon","year":"2022","unstructured":"Jeon D, Park BH, Lee HC, Park Y, Lee W, Lee JH, et al. The impact of pylorus preservation on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy: a historical cohort study. J Hepatobiliary Pancreat Sci. 2022;29:863\u201373. https:\/\/doi.org\/10.1002\/JHBP.1150.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1409_CR43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/MPA.0000000000002070","volume":"51","author":"M Tani","year":"2022","unstructured":"Tani M, Maehira H, Iida H, Mori H, Miyake T, Nitta N. The change in the fibrosis-4 index for the assessment of liver fibrosis after pancreaticoduodenectomy. Pancreas Pancreas. 2022;51:624\u20137. https:\/\/doi.org\/10.1097\/MPA.0000000000002070.","journal-title":"Pancreas Pancreas"},{"key":"1409_CR44","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/AGS3.12572","volume":"6","author":"M Tsunematsu","year":"2022","unstructured":"Tsunematsu M, Gocho T, Yanagaki M, Shirai Y, Haruki K, Furukawa K, et al. The impact of postoperative exocrine index on non-alcoholic fatty liver disease following pancreaticoduodenectomy. Ann Gastroenterol Surg. 2022;6:704\u201311. https:\/\/doi.org\/10.1002\/AGS3.12572.","journal-title":"Ann Gastroenterol Surg"},{"key":"1409_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/AGS3.12554","volume":"6","author":"K Yamamura","year":"2022","unstructured":"Yamamura K, Yamashita Y, Yamao T, Kitano Y, Arima K, Miyata T, et al. Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. Ann Gastroenterol Surg. 2022;6:555\u201361. https:\/\/doi.org\/10.1002\/AGS3.12554.","journal-title":"Ann Gastroenterol Surg"},{"key":"1409_CR46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jceh.2023.05.006","volume":"13","author":"Z Li","year":"2023","unstructured":"Li Z, Weinstein J, Redstone E, Mitchell DG. Hepatic steatosis after partial pancreatectomy in a cohort of patients with intraductal papillary mucinous neoplasm. J Clin Exp Hepatol Elsevier B V. 2023;13:955\u201361. https:\/\/doi.org\/10.1016\/j.jceh.2023.05.006.","journal-title":"J Clin Exp Hepatol Elsevier B V"},{"key":"1409_CR47","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/AGS3.12673","volume":"7","author":"H Izumi","year":"2023","unstructured":"Izumi H, Yoshii H, Fujino R, Takeo S, Nomura E, Mukai M, et al. Factors contributing to nonalcoholic fatty liver disease (NAFLD) and fat deposition after pancreaticoduodenectomy: a retrospective analysis. Ann Gastroenterol Surg. 2023;7:793\u20139. https:\/\/doi.org\/10.1002\/AGS3.12673.","journal-title":"Ann Gastroenterol Surg"},{"key":"1409_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002306","volume":"53","author":"M Tsunematsu","year":"2024","unstructured":"Tsunematsu M, Haruki K, Shirai Y, Onda S, Furukawa K, Okui N, et al. The signal intensity ratio of pancreas to spleen in magnetic resonance imaging can predict nonalcoholic fatty liver disease after pancreaticoduodenectomy. Pancreas. 2024;53:E310\u20136. https:\/\/doi.org\/10.1097\/MPA.0000000000002306.","journal-title":"Pancreas"},{"key":"1409_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.51821\/87.3.10078","volume":"87","author":"V D\u2019cruz","year":"2024","unstructured":"D\u2019cruz V, De Zutter A, Van den Broecke M, Ribeiro S, Abreu de Carvalho L, Smeets P, et al. Prevalence of metabolic dysfunction-associated fatty liver disease after pancreatic surgery in a historical Belgian cohort and review of the literature. Acta Gastroenterol Belg Acta Gastroenterol Belg. 2024;87:373\u201380. https:\/\/doi.org\/10.51821\/87.3.10078.","journal-title":"Acta Gastroenterol Belg Acta Gastroenterol Belg"},{"key":"1409_CR50","doi-asserted-by":"publisher","unstructured":"Uchida Y, Fujii T, Takahashi H, Nakaoka K, Funasaka K, Ohno E, et al. Alterations in the gut microbiota in patients with long-term follow-up after pancreaticoduodenectomy and their association with postoperative fatty liver: a pilot study. Pancreatology. 2024;24:1348\u201354. https:\/\/doi.org\/10.1016\/j.pan.2024.10.005.","DOI":"10.1016\/j.pan.2024.10.005"},{"key":"1409_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/S12664-025-01777-5","author":"V Antony","year":"2025","unstructured":"Antony V, Pillai A, Das MT, Rajan R. Change in liver fat content in patients following pancreatic resections. Indian J Gastroenterol Indian J Gastroenterol. 2025. https:\/\/doi.org\/10.1007\/S12664-025-01777-5.","journal-title":"Indian J Gastroenterol Indian J Gastroenterol"},{"key":"1409_CR52","doi-asserted-by":"publisher","unstructured":"Zhen TT, Li SZ, Pan ST, Yin TY, Wang M, Guo XJ, et al. Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy: A retrospective cohort study. World J Gastroenterol World J Gastroenterol. 2025;31. https:\/\/doi.org\/10.3748\/WJG.V31.I13.104046.","DOI":"10.3748\/WJG.V31.I13.104046"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01409-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01409-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01409-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:11:26Z","timestamp":1770034286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01409-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01409-x","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a narrative literature review and did not involve human participants or the collection of clinical or personal data. Therefore, informed consent and ethical approval were not required. The authors confirm that no identifiable patient information is included in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Responsibilities"}},{"value":"The authors declare no conflicts of interest related to the content of this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"30"}}